title: Conversion from tacrolimus to Neoral in liver and kidney transplant recipients.
authors.affiliation: Department of Surgery, University of Erlangen, Erlangen, Germany.
authors.forename: R
authors.initials: R
authors.lastname: Ott
authors.forename: M
authors.initials: M
authors.lastname: Bussenius-Kammerer
authors.forename: D
authors.initials: D
authors.lastname: Scholz
authors.forename: R
authors.initials: R
authors.lastname: Neuhaus
authors.forename: R H
authors.initials: RH
authors.lastname: Tolba
authors.forename: L
authors.initials: L
authors.lastname: Fricke
authors.forename: V
authors.initials: V
authors.lastname: Müller
mesh_terms: D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine; D016559:Tacrolimus